Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Frederick S. Buckner

Department of Medicine

University of Washington

Seattle

Washington

USA

[email]@u.washington.edu

Name/email consistency: high

[Claim this account]

Affiliations

Department of Medicine, University of Washington, Seattle, Washington, USA. 2000 - 2012
Department of Medicine, Division of Allergy & Infectious Diseases, University of Washington, Seattle, USA. 1997 - 2010

References

Pharmacological characterization, structural studies, and in vivo activities of anti-Chagas disease lead compounds derived from tipifarnib. Buckner, F.S., Bahia, M.T., Suryadevara, P.K., White, K.L., Shackleford, D.M., Chennamaneni, N.K., Hulverson, M.A., Laydbak, J.U., Chatelain, E., Scandale, I., Verlinde, C.L., Charman, S.A., Lepesheva, G.I., Gelb, M.H. Antimicrob. Agents Chemother. (2012) [Pubmed]
Advances in Chagas disease drug development: 2009-2010. Buckner, F.S., Navabi, N. Curr. Opin. Infect. Dis. (2010) [Pubmed]
Sterol 14-demethylase inhibitors for Trypanosoma cruzi infections. Buckner, F.S. Adv. Exp. Med. Biol. (2008) [Pubmed]
Colorimetric assay for screening compounds against Leishmania amastigotes grown in macrophages. Buckner, F.S., Wilson, A.J. Am. J. Trop. Med. Hyg. (2005) [Pubmed]
Cloning and analysis of Trypanosoma cruzi lanosterol 14alpha-demethylase. Buckner, F.S., Joubert, B.M., Boyle, S.M., Eastman, R.T., Verlinde, C.L., Matsuda, S.P. Mol. Biochem. Parasitol. (2003) [Pubmed]
A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents. Buckner, F., Yokoyama, K., Lockman, J., Aikenhead, K., Ohkanda, J., Sadilek, M., Sebti, S., Van Voorhis, W., Hamilton, A., Gelb, M.H. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
Potent anti-Trypanosoma cruzi activities of oxidosqualene cyclase inhibitors. Buckner, F.S., Griffin, J.H., Wilson, A.J., Van Voorhis, W.C. Antimicrob. Agents Chemother. (2001) [Pubmed]
Cloning and heterologous expression of the Trypanosoma brucei lanosterol synthase gene. Buckner, F.S., Nguyen, L.N., Joubert, B.M., Matsuda, S.P. Mol. Biochem. Parasitol. (2000) [Pubmed]
Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase. Buckner, F.S., Wilson, A.J., Van Voorhis, W.C. Infect. Immun. (1999) [Pubmed]
Induction of resistance to azole drugs in Trypanosoma cruzi. Buckner, F.S., Wilson, A.J., White, T.C., Van Voorhis, W.C. Antimicrob. Agents Chemother. (1998) [Pubmed]
Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes. Buckner, F.S., Wipke, B.T., Van Voorhis, W.C. Eur. J. Immunol. (1997) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.